Page tree
Skip to end of metadata
Go to start of metadata

ACTG Study 5257, “The ARDENT Study: Atazanavir, Raltegravir, or Darunavir With Emtricitabine/Tenofovir for Naive Treatment,” 2009–2013

Found 1 search result(s) for ARDENT OR 5257.

Page: 3.5 Daria Hazuda: Discovery and Development of Integrase Inhibitors (HIV/AIDS Research: Its History & Future Meeting)
... International AIDS Conference, Vancouver, Canada, July 1996 ACTG Study 5257 "ARDENT" (2009–2013)  adherence, patient compliance Amgen (Applied Molecular Genetics ... ...
Apr 27, 2021

  • No labels